Picture this: a private jet touches down at dawn. Within an hour, the passenger is settled into a mountain retreat, not for a board meeting or ski trip, but for a week of comprehensive metabolic testing, epigenetic analysis – how your lifestyle and environment have affected your genes’ activity – and personalised longevity planning. Or perhaps they’re checking into a five-star hotel, one where their suite comes with biological age assessments alongside the usual luxury amenities.

Gone are the days when medical tourism meant bargain dental work in Bangkok or cut-price cosmetic surgery in Seoul. Today’s elite medical travellers are pursuing something far more ambitious: optimising their biological age, preventing disease decades before symptoms appear and essentially buying time.

Don So, CEO of Humansa, is banking on this transformation. The Hong Kong health and longevity company has established Humansa Suisse at The Chedi Andermatt – a five-star Swiss resort where guests can now book everything from weekend programmes to comprehensive health optimisation journeys.

“Travellers now want more than comfort – they want science-backed, medical-grade wellness that delivers real recovery during their stay,” So says. Humansa’s methodology includes biological age assessments; VO Max testing, which measures the maximum oxygen your body can use during exercise – a key indicator of cardiovascular fitness and longevity; cardio-metabolic evaluations, which assess your heart health and how efficiently your body processes energy and burns calories; and cognitive function analysis. The programme also uses modernised Traditional Chinese Medicine (TCM) – but only practices backed by scientific evidence.

“TCM’s holistic focus on restoring the body’s balance perfectly complements the precision of Western science,” So explains. “This synergy allows us to offer a deeply personalised path to vitality.” He says that the company ensures continuity through digital platforms that track progress long after guests leave the Alps.

While Switzerland has long dominated the luxury medical wellness sector, Singapore is emerging as Asia’s answer to alpine wellness. In January 2025, at Four Seasons Hotel Singapore, Chi Longevity opened a clinic that exemplifies this new breed of hotel-based medical facility.

Professor Andrea Maier, the clinic’s co-founder and founding president of the Healthy Longevity Medicine Society, says of their clientele: “We attract individuals operating at the highest levels of influence, responsibility and performance – leaders, investors, founders and multi-generational family principals who rely on cognitive clarity, physical vitality and long-term functional independence.”

The assessments at Chi Longevity sound like science fiction. Epigenetic ageing clocks measure how fast you’re ageing at the cellular level compared to your chronological age; microbiome ageing signatures analyse the bacteria in your gut to determine your biological age; inflammation age clocks measure chronic inflammation markers in your body to assess ageing; and blood-based biomarkers reflect physiological age, with startling accuracy.

“These advanced insights allow us to create a comprehensive biological map that informs the personalised interventions central to healthy longevity,” Maier says.

The Maier Method then translates these findings into evidence-based interventions across therapeutics, nutrition, movement, sleep, stress and psychosocial well-being.

The marriage of luxury and medicine represents a fundamental innovation. Eva-Maria Hasenauer, CCO of the Austria-based Lanserhof Group that are behind luxury medical resort brand The Lanserhof, says, “In modern healthcare, ‘luxury’ is defined less by extravagance and more by the quality of attention, personalisation and experience.”

The Lanserhof has four locations – the first in Austria, two in Germany, and a clinic in London, with one more opening in Spain in 2027. The Lanserhof’s most sought-after services include comprehensive metabolic and genetic testing, full-body imaging, hormonal and microbiome analysis and longevity assessments that detect risks long before symptoms appear. These aren’t spa treatments masquerading as medicine – they’re interventions designed to help prevent potentially life-threatening disease.

Yet Hasenauer warns against false impressions: “One of the main misconceptions is the idea that elite destination-based healthcare is simply ‘wellness packaged in luxury’. In reality, when done properly, it is deeply medical, highly diagnostic and rooted in prevention – not indulgence.”

The challenge is continuity. A week in the Alps or a weekend in Singapore creates momentum, but transformation requires sustained commitment. That’s why providers are building elaborate digital ecosystems. Humansa offers programmes with relationship managers. Chi Longevity maintains ongoing support through online portals and health coaches. Lanserhof provides detailed reports and long-term recommendations that extend far beyond the stay.

This is healthcare as legacy planning. Many approach The Lanserhof as a partner in long-term health optimisation, says Hasenauer – they’re “using regular stays and continuous follow-up to track biological ageing, prevent disease and maintain peak performance over the years”.

As these clinics proliferate, they’re reshaping destinations. Singapore leverages its regulatory strength to position itself as a hub for evidence-based longevity. Switzerland attracts those seeking what So calls “productive leisure” – holidays delivering measurable health improvements.

The ultra-wealthy have always bought better healthcare. But this is different – they’re not just treating disease, but potentially “purchasing” decades, even, of life. The mega-yacht can wait.

“For many high-net-worth families, [longevity clinics] may indeed become a new status symbol,” says Hasenauer, “reflecting a commitment to health as a core part of their legacy.”